The future holds a lot of interesting chapters for Beloorbayir Biotech Limited.

We believe that by 2020, we will hold a place in the Top 50 list of healthcare companies in India, as the foundation to propel this growth has already been laid. There is no doubt whatsoever that the company will emerge as a leading provider of proven alternative health ingredients in the global nutraceutical market. The company has significant current and future investment in R&D, including clinical studies; it has over 25 ingredients in the pipeline for future release and will have at least five patents by the end of 2025.

Included in this research and development activity are breakthrough innovations in cosmetic ingredients and new delivery systems. 2016 has seen the launch of path breaking ingredients in the nanoparticles and active pharmaceutical ingredient spaces. These new products alone will generate significant growth for the organisation and constitute 30% of overall sales turnover.
The company has invested in the field of nanotechnology, and most of its future products will be based on this platform, which redefines dosage forms and bioavailability.

The company has invested in being a leader in the Nano technology area and most of its future products will be based on this platform redefining dosage forms and bioavailability.